Primary or Recurrent Breast Carcinoma: Clinical Trials

1 trial for Primary or Recurrent Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Primary or Recurrent Breast Carcinoma: new trials by email Literature Review of Primary or Recurrent Breast Carcinoma trials Research Report on Primary or Recurrent Breast Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
F-18 16 Alpha-Fluoroestradiol, Positron Emission Tomography, Computed Tomography - Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma
Phase 2Active not recruitingUniversity of Washington22021-07-102026-07-01

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

16-fluoroestradiol (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  X-Rays (1)

Sponsors

University of Washington (1)

Countries

United States (1)

Top investigators

Hannah Linden (1)